-
Based on emerging evidence, there are increased efforts around the world to maintain strict glycemic control in non-diabetic critically ill patients. Management of hyperglycemia through the use of insulin protocols is a new standard in critical care. Several protocols have been evaluated and reported in the literature.
-
A Crackdown on Importation of Drugs; FDA Actions.
-
-
-
The Department of Health and Human Services (HHS) has placed a draft influenza preparedness and response plan on its web site. This detailed document provides useful advice about health care system guidance on staffing, infection control, and strategies to limit transmission of infection within health care institutions.
-
This study found no evidence that the use of narcotics or benzodiazepines to treat discomfort after the withdrawal of life support hastens death in critically ill patients at our center. Clinicians should strive to control patient symptoms in this setting and should document the rationale for escalating drug doses.
-
-
The 6 articles in the December 1, 2004, issue of JAMA represent a detailed overview of drug safety in the United States. The withdrawal of cerivastatin reflects the current situation, and problems with antidepressants in youngsters and, more recently, the identification of adverse reactions with the 3 Cox-2 inhibitors, raise important questions regarding the ability of the FDA to effectively police adverse drug reactions after release of a drug.
-
-
The addition of niacin to patients with known coronary artery disease on statins raised HDL cholesterol and reduced atherosclerosis progression.
